SECTION I: Testing
1 |
Has the R & D result been tested? | |
YES |
x | |
NO |
||
The following question is replied according to the reply in question 1
If yes
1a |
In what mode has the result been tested?
• Prototype • Pilot Application • Alpha/BETA testing
|
|
Tests were carried out on rats and mice.
|
||
1b. | Please describe and discuss the testing results | |
Muscle regeneration is faster with 20-30%. Near low transfection rate reaches high and fast muscle-wide regeneration.
|
||
If no:
1c |
Describe what type of testing does the R&D result need? | |
Detailed comment
|
||
1d. | What is the time needed for testing? | |
1e. | What is the cost needed for testing? | |
SECTION 2: Current Stage of Development
2a |
To what extent does the development team have technical resources for supporting the production of a new product? (Researchers, human resources, hardware, etc. ) |
A preclinical labor is needed, but they have not any.
|
2b |
What are the technical issues that need to be tackled for full deployment, if needed? |
Neither human nor toxicology testing was not yet done. Sick mice (wasting) was not tested.
|
2c |
What additional technical resources are needed for the production of this new product? |
They are looking for product development partners to develop the transfection kit through a licence agreement. |
2d |
Overall assessment of the current stage of technical development. |
The basic research stage has been successfully closed; development is now entering the preclinical trial phase.
|
SECTION 3: Deployment
3a |
Define the demands for large scale production in terms of |
|
|
|
|
|
|
|
|
|
|
|
SECTION 4: Overall Assessment
1 |
What is you overall assessment of the technical feasibility of the research result? |
The research stage has been successfully closed; development is now entering the preclinical trial phase.
They are looking for product development partners to develop the transfection kit through a licence agreement.
|
KEYWORDS QUANTITATIVE ASSESSMENT (0-5).
Please put X as appropriate. | 1 | 2 | 3 | 4 | 5 |
Adequacy of testing activity undertaken so far | X | ||||
Adequacy and availability of technical resources of the development team | X | ||||
Current development stage | X | ||||
Overall technical feasibility | X |